NeuroDerm Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Employees
-
173
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1.1B
NeuroDerm General Information
Description
Operator of a clinical-stage pharmaceutical company intended to develop next-generation treatments for central nervous system disorders. The company specialzies in developing pharmaceutical drugs for central nervous system disorders and deficiencies in Parkinson's disease and central nervous system disorder treatments, thereby enabling patients to improve their quality of lives.
Contact Information
Website
www.neuroderm.com(Operating Subsidiary)
Corporate Office
- 3 Haim Pekeris Street, Ruhrberg Science Building
- Bell Entrance, 4th floor, Rabin Science Park
- Rehovot 7670212
- Israel
Corporate Office
- 3 Haim Pekeris Street, Ruhrberg Science Building
- Bell Entrance, 4th floor, Rabin Science Park
- Rehovot 7670212
- Israel
NeuroDerm Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Merger/Acquisition | 18-Oct-2017 | $1.1B | Completed | Profitable | ||
| 12. 2PO | 28-Sep-2016 | Completed | Generating Revenue | |||
| 11. Secondary Transaction - Open Market | 15-Mar-2016 | Completed | Generating Revenue | |||
| 10. PIPE | 24-Jun-2015 | Completed | Clinical Trials - Phase 2 | |||
| 9. IPO | 14-Nov-2014 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 31-Aug-2014 | Completed | Generating Revenue | |||
| 7. Grant | 03-Jun-2013 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 16-Jul-2012 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 23-Jul-2011 | $2.5M | $3.1M | Completed | Generating Revenue | |
| 4. Grant | 06-Oct-2010 | $1M | $600K | Completed | Generating Revenue |
NeuroDerm Comparisons
Industry
Financing
Details
NeuroDerm Competitors (36)
One of NeuroDerm’s 36 competitors is CervoMed, a Formerly VC-backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CervoMed | Formerly VC-backed | Boston, MA | ||||
| CuraSen | Venture Capital-Backed | San Carlos, CA | ||||
| Cytokinetics | Formerly VC-backed | South San Francisco, CA | ||||
| Prilenia | Venture Capital-Backed | Naarden, Netherlands | ||||
| Neurona Therapeutics | Formerly VC-backed | South San Francisco, CA |
NeuroDerm Patents
NeuroDerm Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025253369-A1 | Automatic cannula inserter with reusable and disposable parts | Pending | 04-Jun-2024 | ||
| AU-2024250257-A1 | Methods and compositions for reducing symptoms of parkinson's disease | Pending | 14-Apr-2023 | ||
| EP-4694877-A1 | Methods and compositions for reducing symptoms of parkinson's disease | Pending | 14-Apr-2023 | ||
| US-12161612-B2 | Methods and compositions for reducing symptoms of parkinson's disease | Active | 14-Apr-2023 | ||
| US-20240342124-A1 | Methods and compositions for reducing symptoms of parkinson's disease | Active | 14-Apr-2023 | A61K31/195 |
NeuroDerm Signals
NeuroDerm Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ben-Gurion University of the Negev | University | Majority | ||
| Capital Point | Venture Capital | Minority | ||
| Elias Group | Corporation | Minority | ||
| Foresite Capital | Growth/Expansion | Minority | ||
| Ofakim Hi-Tech Ventures | Accelerator/Incubator | Minority |
NeuroDerm FAQs
-
When was NeuroDerm founded?
NeuroDerm was founded in 2003.
-
Where is NeuroDerm headquartered?
NeuroDerm is headquartered in Rehovot, Israel.
-
What is the size of NeuroDerm?
NeuroDerm has 173 total employees.
-
What industry is NeuroDerm in?
NeuroDerm’s primary industry is Drug Discovery.
-
Is NeuroDerm a private or public company?
NeuroDerm is a Private company.
-
What is the current valuation of NeuroDerm?
The current valuation of NeuroDerm is .
-
What is NeuroDerm’s current revenue?
The current revenue for NeuroDerm is .
-
How much funding has NeuroDerm raised over time?
NeuroDerm has raised $79.1M.
-
Who are NeuroDerm’s investors?
Ben-Gurion University of the Negev, Capital Point, Elias Group, Foresite Capital, and Ofakim Hi-Tech Ventures have invested in NeuroDerm.
-
Who are NeuroDerm’s competitors?
CervoMed, CuraSen, Cytokinetics, Prilenia, and Neurona Therapeutics are some of the 36 competitors of NeuroDerm.
-
When was NeuroDerm acquired?
NeuroDerm was acquired on 18-Oct-2017.
-
Who acquired NeuroDerm?
NeuroDerm was acquired by Tanabe Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process